Literature DB >> 15517612

Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes.

Lionel Arlettaz1, Jean Villard, Casimir de Rham, Sylvie Degermann, Bernard Chapuis, Bertrand Huard, Eddy Roosnek.   

Abstract

A subset of CD8(+) T cells express the natural killer cell receptors CD94:NKG2A or CD94:NKG2C. We found that although many CD8(+) T cells transcribe CD94 and NKG2C, expression of a functional CD94:NKG2C receptor is restricted to highly differentiated effector cells. CD94:NKG2A is expressed by a different subset consisting of CCR7(+) memory cells and CCR7(-) effector cells. Since NKG2A can only be induced on naive CD8(+) T cells while CD94(-) memory cells are refractory, it is likely that commitment to the CD94:NKG2A(+) subset occurs during the first encounter with antigen. CCR7(+)CD94:NKG2A(+) T cells recirculate through lymph nodes where upon activation, they produce large quantities of IFN-gamma. These cells occur as a separate CD94:NKG2A(+) T cell lineage with a distinct TCR repertoire that differs from that of the other CD8(+)CD94(-) T cells activated in situ.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15517612     DOI: 10.1002/eji.200425210

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  21 in total

1.  Umbilical cord blood T cells express multiple natural cytotoxicity receptors after IL-15 stimulation, but only NKp30 is functional.

Authors:  Qin Tang; Bartosz Grzywacz; Hongbo Wang; Nandini Kataria; Qing Cao; John E Wagner; Bruce R Blazar; Jeffrey S Miller; Michael R Verneris
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  Therapeutic CD94/NKG2A blockade improves natural killer cell dysfunction in chronic lymphocytic leukemia.

Authors:  Emily M McWilliams; Jennifer M Mele; Carolyn Cheney; Elizabeth A Timmerman; Faraz Fiazuddin; Ethan J Strattan; Xiaokui Mo; John C Byrd; Natarajan Muthusamy; Farrukh T Awan
Journal:  Oncoimmunology       Date:  2016-09-09       Impact factor: 8.110

3.  Impact of Zygosity on Bimodal Phenotype Distributions.

Authors:  Thomas Holst-Hansen; Elena Abad; Aura Muntasell; Miguel López-Botet; Mogens H Jensen; Ala Trusina; Jordi Garcia-Ojalvo
Journal:  Biophys J       Date:  2017-07-11       Impact factor: 4.033

4.  Increases in NKG2C Expression on T Cells and Higher Levels of Circulating CD8+ B Cells Are Associated with Sterilizing Immunity Provided by a Live Attenuated SIV Vaccine.

Authors:  Vida L Hodara; Laura M Parodi; M Shannon Keckler; Luis D Giavedoni
Journal:  AIDS Res Hum Retroviruses       Date:  2016-03-17       Impact factor: 2.205

5.  Human antimicrobial cytotoxic T lymphocytes, defined by NK receptors and antimicrobial proteins, kill intracellular bacteria.

Authors:  Samuel J Balin; Matteo Pellegrini; Eynav Klechevsky; Sohui T Won; David I Weiss; Aaron W Choi; Joshua Hakimian; Jing Lu; Maria Teresa Ochoa; Barry R Bloom; Lewis L Lanier; Steffen Stenger; Robert L Modlin
Journal:  Sci Immunol       Date:  2018-08-31

6.  Human cytomegalovirus expands a CD8+ T cell population with loss of BCL11B expression and gain of NK cell identity.

Authors:  Rosa Sottile; M Kazim Panjwani; Colleen M Lau; Anthony F Daniyan; Kento Tanaka; Juliet N Barker; Renier J Brentjens; Joseph C Sun; Jean-Benoît Le Luduec; Katharine C Hsu
Journal:  Sci Immunol       Date:  2021-09-24

7.  Differential induction of CD94 and NKG2 in CD4 helper T cells. A consequence of influenza virus infection and interferon-gamma?

Authors:  Christine M Graham; Jillian R Christensen; D Brian Thomas
Journal:  Immunology       Date:  2007-06       Impact factor: 7.397

8.  NKp46+ CD3+ cells: a novel nonconventional T cell subset in cattle exhibiting both NK cell and T cell features.

Authors:  Timothy K Connelley; Cassandra Longhi; Alison Burrells; Kathryn Degnan; Jayne Hope; Alasdair J Allan; John A Hammond; Anne K Storset; W Ivan Morrison
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

9.  Increased HLA-E expression in white matter lesions in multiple sclerosis.

Authors:  Pascal F Durrenberger; Louise V Webb; Malcolm J W Sim; Richard S Nicholas; Daniel M Altmann; Rosemary J Boyton
Journal:  Immunology       Date:  2012-12       Impact factor: 7.397

10.  Broadly targeted CD8⁺ T cell responses restricted by major histocompatibility complex E.

Authors:  Scott G Hansen; Helen L Wu; Benjamin J Burwitz; Colette M Hughes; Katherine B Hammond; Abigail B Ventura; Jason S Reed; Roxanne M Gilbride; Emily Ainslie; David W Morrow; Julia C Ford; Andrea N Selseth; Reesab Pathak; Daniel Malouli; Alfred W Legasse; Michael K Axthelm; Jay A Nelson; Geraldine M Gillespie; Lucy C Walters; Simon Brackenridge; Hannah R Sharpe; César A López; Klaus Früh; Bette T Korber; Andrew J McMichael; S Gnanakaran; Jonah B Sacha; Louis J Picker
Journal:  Science       Date:  2016-01-21       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.